Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms, Unknown Primary 1Neoplasms 1Genetic Predisposition to Disease 1Disease 1

Interventions

Blood Specimen Collection 6pembrolizumab 2fluciclovine F-18 2Surveys and Questionnaires 2Preoperative Exercise 2Magnetic Resonance Imaging 2Exercise 2Cryosurgery 2Bevacizumab 2tislelizumab 1neratinib 1imetelstat 1daratumumab 1atezolizumab 1abiraterone 1Waiting Lists 1Videotape Recording 1Urine Specimen Collection 1Triamcinolone Acetonide 1Transcutaneous Electric Nerve Stimulation 1Tomography, X-Ray Computed 1Thoracic Surgical Procedures 1TIC10 compound 1Sulfonylurea Compounds 1Standard of Care 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Serologic Tests 1Sequence Analysis, RNA 1S-Adenosylmethionine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Sequence Analysis, RNA × 1 year × Clear all
NCT04620278 2026-01-06

Genetic Investigation of Cancer Predisposition

The University of Texas Health Science Center at San Antonio

Not yet recruiting
100 enrolled

Disease, Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡